Difference between revisions of "Abbreviations List"
(Created page with " {|class="wikitable" style="text-align:center" |- ! Acronym ! Name ! Species Type |- | 12-LOX | 12-Lipoxygenase | Enzyme |- | 15-D-PGJ2 | 15-Deoxy-Cyclopentenone Prostaglandi...") |
|||
Line 1: | Line 1: | ||
− | + | {| class="wikitable" | |
− | {|class="wikitable" | + | ! Abbreviation !! Name |
|- | |- | ||
− | + | | [E]0 || Enzyme concentration | |
− | |||
− | |||
|- | |- | ||
− | | | + | | 15-PGDH || 15 hydroxy prostaglandin dehydrogenase |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | 46BR.1N || 46BR dermal fibroblasts |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | 5-HEDH || 5-hydroxyeicosanoid dehydrogenase |
− | | | ||
− | |||
|- | |- | ||
− | | | + | | AA || Arachidonic acid |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | ABC || ATP-binding cassette transporters |
− | | | ||
− | |||
|- | |- | ||
− | | | + | | ABC_CI || ATP-binding cassette transporter competitive inhibition term |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | ACS || American chemical society |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | AKR13 || Aldo-keto reductase family 1 member C3 |
− | | | ||
− | |||
|- | |- | ||
− | | | + | | ATP || Adenosine 5′-triphosphate |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | BCA || Bicinchoninic acid |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | BHT || 2, 6-ditert-butyl-4-methylphenol |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | BSA || Bovine serum albumin |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | COX || Cyclooxygenase |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | cPGES || Cytosolic Prostaglandin E Synthase |
− | | Prostaglandin | ||
− | |||
|- | |- | ||
− | | | + | | CYP P450 || Cytochrome P450 |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | DC || Dendritic cells |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | DCM || Dichloromethane |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | DGLA || Cis-8,11,14-eicosatrienoic acid |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | DHA || Cis-4,7,10,13,16,19-docosahexaenoic acid |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | DMEM || Dulbecco’s modified eagle medium |
− | | | ||
− | | | ||
|- | |- | ||
− | | | + | | DMSO || Dimethyl sulfoxide |
− | | | ||
− | | | ||
|- | |- | ||
− | | TXAS | + | | DT || Doubling time |
− | | Thromboxane A | + | |- |
− | | | + | | DTT || Dithiothreitol |
+ | |- | ||
+ | | EC || Endothelial cell | ||
+ | |- | ||
+ | | EDTA || Ethylenediaminetetraacetic acid | ||
+ | |- | ||
+ | | EPA || Cis-5,8,11,14,17-Eicosapentaenoic acid | ||
+ | |- | ||
+ | | ER || Endoplasmic reticulum | ||
+ | |- | ||
+ | | ESI || Electrospray ionisation | ||
+ | |- | ||
+ | | FAME || Fatty acids methyl esters | ||
+ | |- | ||
+ | | FBS || Foetal bovine serum | ||
+ | |- | ||
+ | | FID || Flame ionisation detector | ||
+ | |- | ||
+ | | FLAP || Arachidonate 5-lipoxygenase-activating protein | ||
+ | |- | ||
+ | | GC || Gas chromatography | ||
+ | |- | ||
+ | | GCV || Geometric coefficient of variation | ||
+ | |- | ||
+ | | HaCaT || Human adult low-calcium high-temperature keratinocyte | ||
+ | |- | ||
+ | | HETE || Hydroxy-eicosatetraenoic acid | ||
+ | |- | ||
+ | | HL || Half-life | ||
+ | |- | ||
+ | | HPETE || Hydroperoxy-eicosatetraenoic acid | ||
+ | |- | ||
+ | | H-PGDS || Hemopoietic PGDS | ||
+ | |- | ||
+ | | HPLC || High performance liquid chromatography | ||
+ | |- | ||
+ | | IQR || Inter quartile range | ||
+ | |- | ||
+ | | IS || Internal standard | ||
+ | |- | ||
+ | | kcat || Enzyme turnover number | ||
+ | |- | ||
+ | | KDO2-lipid A || Di[3-deoxy-D-manno-octulosonyl]-lipid A | ||
+ | |- | ||
+ | | Keq || Equilibrium constant | ||
+ | |- | ||
+ | | Kf || Forward reaction rate constant | ||
+ | |- | ||
+ | | Ki || Inhibitor constant | ||
+ | |- | ||
+ | | KD || Dissociation constant of the enzyme-substrate complex | ||
+ | |- | ||
+ | | Kmp || Michaelis constant for the product | ||
+ | |- | ||
+ | | Kms || Michaelis constant for the substrate | ||
+ | |- | ||
+ | | Kr || Reverse reaction rate constant | ||
+ | |- | ||
+ | | KS test || Kolmogorov–Smirnov test | ||
+ | |- | ||
+ | | LC || Liquid chromatography | ||
+ | |- | ||
+ | | LDL || Low density lipid | ||
+ | |- | ||
+ | | LL || Log likelihood function | ||
+ | |- | ||
+ | | LOX || Lipoxygenase | ||
+ | |- | ||
+ | | L-PGDS || Lipocalin PGDS | ||
+ | |- | ||
+ | | LT || Leukotriene | ||
+ | |- | ||
+ | | LTA4H || Leukotriene A4 hydrolase | ||
+ | |- | ||
+ | | LTC4S || Leukotriene C4 synthase | ||
+ | |- | ||
+ | | MAA || Membrane arachidonic acid | ||
+ | |- | ||
+ | | MALDI-TOF || Matrix assisted laser desorption ionization-time of flight | ||
+ | |- | ||
+ | | MEME || Minimum essential medium eagle | ||
+ | |- | ||
+ | | mPGES || Microsomal PGES | ||
+ | |- | ||
+ | | MRM || Multiple reaction monitoring | ||
+ | |- | ||
+ | | MS || Mass spectrometry | ||
+ | |- | ||
+ | | MTOI || Multiple target optimal intervention | ||
+ | |- | ||
+ | | MTT || 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide | ||
+ | |- | ||
+ | | n-3 PUFA || Omega-3 polyunsaturated fatty acid | ||
+ | |- | ||
+ | | n-6 PUFA || Omega-6 polyunsaturated fatty acid | ||
+ | |- | ||
+ | | NAD/NADH || Nicotinamide adenine dinucleotide | ||
+ | |- | ||
+ | | NADP/NADPH || Nicotinamide adenine dinucleotide phosphate | ||
+ | |- | ||
+ | | NSAID || Nonsteroidal anti-inflammatory drug | ||
+ | |- | ||
+ | | ODEs || Ordinary differential equations | ||
+ | |- | ||
+ | | OxoETE || Oxo-eicosatetraenoic acid | ||
+ | |- | ||
+ | | P || Product | ||
+ | |- | ||
+ | | PAF || Platelet-activating factor | ||
+ | |- | ||
+ | | PBS || Dulbecco’s phosphate buffered saline | ||
+ | |- | ||
+ | | PC || Phosphatidylcholine | ||
+ | |- | ||
+ | | PDEs || Partial differential equations | ||
+ | |- | ||
+ | | PE || Phosphatidylethanolamine | ||
+ | |- | ||
+ | | PG || Prostaglandin | ||
+ | |- | ||
+ | | PGDS || Prostaglandin D synthase | ||
+ | |- | ||
+ | | PGES || Prostaglandin E synthase | ||
+ | |- | ||
+ | | PGFS || Prostaglandin F synthase | ||
+ | |- | ||
+ | | PGIS || Prostaglandin I synthase | ||
+ | |- | ||
+ | | PGT || Prostaglandin transporter | ||
+ | |- | ||
+ | | PGT_CI || Prostaglandin transporter competitive inhibition term | ||
+ | |- | ||
+ | | PHGPx || Phospholipid hydroperoxide glutathione peroxidase | ||
+ | |- | ||
+ | | PKU || Phenylketonuria | ||
+ | |- | ||
+ | | PLA2 || Phospholipase A2 enzyme | ||
+ | |- | ||
+ | | PLT || Platelet cell | ||
+ | |- | ||
+ | | PMN || Human polymorphonuclear leukocyte | ||
+ | |- | ||
+ | | PPARϒ || Peroxisome proliferator-activated receptor γ | ||
+ | |- | ||
+ | | PTGR-2 || Prostaglandin reductase 2 | ||
+ | |- | ||
+ | | PTGR-2 || Prostaglandin reductase 2 | ||
+ | |- | ||
+ | | PUFA || Polyunsaturated fatty acids | ||
+ | |- | ||
+ | | Q || Quadrupole | ||
+ | |- | ||
+ | | R || Gas constant | ||
+ | |- | ||
+ | | S || Substrates | ||
+ | |- | ||
+ | | SPE || Solid-phase extraction | ||
+ | |- | ||
+ | | SRM || Selected reaction monitoring | ||
+ | |- | ||
+ | | SWATH-MS || Sequential window acquisition of all theoretical mass spectra | ||
+ | |- | ||
+ | | Th2 || T helper type 2 cell | ||
+ | |- | ||
+ | | TP || TP receptor | ||
+ | |- | ||
+ | | TX || Thromboxane | ||
+ | |- | ||
+ | | TXAS || Thromboxane A synthase | ||
+ | |- | ||
+ | | UPLC || Ultrahigh performance liquid chromatography | ||
+ | |- | ||
+ | | UV || Ultraviolet | ||
+ | |- | ||
+ | | UVR || Ultraviolet radiation | ||
+ | |- | ||
+ | | Vmax || Maximal rate | ||
|} | |} |
Latest revision as of 13:12, 26 August 2019
Abbreviation | Name |
---|---|
[E]0 | Enzyme concentration |
15-PGDH | 15 hydroxy prostaglandin dehydrogenase |
46BR.1N | 46BR dermal fibroblasts |
5-HEDH | 5-hydroxyeicosanoid dehydrogenase |
AA | Arachidonic acid |
ABC | ATP-binding cassette transporters |
ABC_CI | ATP-binding cassette transporter competitive inhibition term |
ACS | American chemical society |
AKR13 | Aldo-keto reductase family 1 member C3 |
ATP | Adenosine 5′-triphosphate |
BCA | Bicinchoninic acid |
BHT | 2, 6-ditert-butyl-4-methylphenol |
BSA | Bovine serum albumin |
COX | Cyclooxygenase |
cPGES | Cytosolic Prostaglandin E Synthase |
CYP P450 | Cytochrome P450 |
DC | Dendritic cells |
DCM | Dichloromethane |
DGLA | Cis-8,11,14-eicosatrienoic acid |
DHA | Cis-4,7,10,13,16,19-docosahexaenoic acid |
DMEM | Dulbecco’s modified eagle medium |
DMSO | Dimethyl sulfoxide |
DT | Doubling time |
DTT | Dithiothreitol |
EC | Endothelial cell |
EDTA | Ethylenediaminetetraacetic acid |
EPA | Cis-5,8,11,14,17-Eicosapentaenoic acid |
ER | Endoplasmic reticulum |
ESI | Electrospray ionisation |
FAME | Fatty acids methyl esters |
FBS | Foetal bovine serum |
FID | Flame ionisation detector |
FLAP | Arachidonate 5-lipoxygenase-activating protein |
GC | Gas chromatography |
GCV | Geometric coefficient of variation |
HaCaT | Human adult low-calcium high-temperature keratinocyte |
HETE | Hydroxy-eicosatetraenoic acid |
HL | Half-life |
HPETE | Hydroperoxy-eicosatetraenoic acid |
H-PGDS | Hemopoietic PGDS |
HPLC | High performance liquid chromatography |
IQR | Inter quartile range |
IS | Internal standard |
kcat | Enzyme turnover number |
KDO2-lipid A | Di[3-deoxy-D-manno-octulosonyl]-lipid A |
Keq | Equilibrium constant |
Kf | Forward reaction rate constant |
Ki | Inhibitor constant |
KD | Dissociation constant of the enzyme-substrate complex |
Kmp | Michaelis constant for the product |
Kms | Michaelis constant for the substrate |
Kr | Reverse reaction rate constant |
KS test | Kolmogorov–Smirnov test |
LC | Liquid chromatography |
LDL | Low density lipid |
LL | Log likelihood function |
LOX | Lipoxygenase |
L-PGDS | Lipocalin PGDS |
LT | Leukotriene |
LTA4H | Leukotriene A4 hydrolase |
LTC4S | Leukotriene C4 synthase |
MAA | Membrane arachidonic acid |
MALDI-TOF | Matrix assisted laser desorption ionization-time of flight |
MEME | Minimum essential medium eagle |
mPGES | Microsomal PGES |
MRM | Multiple reaction monitoring |
MS | Mass spectrometry |
MTOI | Multiple target optimal intervention |
MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
n-3 PUFA | Omega-3 polyunsaturated fatty acid |
n-6 PUFA | Omega-6 polyunsaturated fatty acid |
NAD/NADH | Nicotinamide adenine dinucleotide |
NADP/NADPH | Nicotinamide adenine dinucleotide phosphate |
NSAID | Nonsteroidal anti-inflammatory drug |
ODEs | Ordinary differential equations |
OxoETE | Oxo-eicosatetraenoic acid |
P | Product |
PAF | Platelet-activating factor |
PBS | Dulbecco’s phosphate buffered saline |
PC | Phosphatidylcholine |
PDEs | Partial differential equations |
PE | Phosphatidylethanolamine |
PG | Prostaglandin |
PGDS | Prostaglandin D synthase |
PGES | Prostaglandin E synthase |
PGFS | Prostaglandin F synthase |
PGIS | Prostaglandin I synthase |
PGT | Prostaglandin transporter |
PGT_CI | Prostaglandin transporter competitive inhibition term |
PHGPx | Phospholipid hydroperoxide glutathione peroxidase |
PKU | Phenylketonuria |
PLA2 | Phospholipase A2 enzyme |
PLT | Platelet cell |
PMN | Human polymorphonuclear leukocyte |
PPARϒ | Peroxisome proliferator-activated receptor γ |
PTGR-2 | Prostaglandin reductase 2 |
PTGR-2 | Prostaglandin reductase 2 |
PUFA | Polyunsaturated fatty acids |
Q | Quadrupole |
R | Gas constant |
S | Substrates |
SPE | Solid-phase extraction |
SRM | Selected reaction monitoring |
SWATH-MS | Sequential window acquisition of all theoretical mass spectra |
Th2 | T helper type 2 cell |
TP | TP receptor |
TX | Thromboxane |
TXAS | Thromboxane A synthase |
UPLC | Ultrahigh performance liquid chromatography |
UV | Ultraviolet |
UVR | Ultraviolet radiation |
Vmax | Maximal rate |